Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006855-10Phase 4Unknown
Phase 4, randomised trial of Lecicarbon, glycerol, bisacodyl, docusate sodium and Micralax in neurogenic bowel (NBD) (5 arms), sponsored by Buckinghamshire Healthcare NHS Trust. Primary endpoint: Total duration of bowel management. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006855-10.